Michael Kann

4.4k total citations · 1 hit paper
67 papers, 3.3k citations indexed

About

Michael Kann is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Michael Kann has authored 67 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 30 papers in Molecular Biology and 22 papers in Hepatology. Recurrent topics in Michael Kann's work include Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (22 papers) and Virus-based gene therapy research (21 papers). Michael Kann is often cited by papers focused on Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (22 papers) and Virus-based gene therapy research (21 papers). Michael Kann collaborates with scholars based in Germany, France and United States. Michael Kann's co-authors include Nelly Panté, Wolfram H. Gerlich, Ari Helenius, Birgit Rabe, Gary R. Whittaker, Dieter Glebe, Beate Sodeik, Andreas Bischof, Marie-Lise Blondot and Volker Bruss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Kann

62 papers receiving 3.2k citations

Hit Papers

Nuclear Pore Complex Is Able to Transport Macromolecules ... 2002 2026 2010 2018 2002 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kann Germany 29 1.7k 1.4k 994 749 649 67 3.3k
Daniel D. Loeb United States 30 1.4k 0.9× 1.4k 1.0× 914 0.9× 287 0.4× 1.2k 1.8× 72 3.2k
Weidong Zhong United States 30 1.9k 1.1× 981 0.7× 1.2k 1.2× 219 0.3× 1.3k 2.0× 61 3.9k
Antonella Folgori Italy 31 1.2k 0.7× 733 0.5× 1.1k 1.1× 299 0.4× 414 0.6× 55 2.6k
N. Cheng United States 16 1.4k 0.8× 803 0.6× 381 0.4× 415 0.6× 374 0.6× 23 2.5k
Rolf E. Streeck Germany 35 2.0k 1.2× 1.5k 1.1× 459 0.5× 974 1.3× 315 0.5× 71 3.7k
Petr Chlanda Germany 20 706 0.4× 1.0k 0.7× 460 0.5× 134 0.2× 1.0k 1.6× 41 2.6k
H. Van Heuverswyn Belgium 18 963 0.6× 983 0.7× 629 0.6× 398 0.5× 278 0.4× 34 2.7k
Rudolf K. Beran United States 19 1.0k 0.6× 826 0.6× 884 0.9× 237 0.3× 236 0.4× 26 1.9k
S L Zebedee United States 16 1.7k 1.0× 973 0.7× 442 0.4× 153 0.2× 399 0.6× 18 2.6k
Thomas Krey Germany 25 801 0.5× 589 0.4× 859 0.9× 152 0.2× 460 0.7× 56 2.2k

Countries citing papers authored by Michael Kann

Since Specialization
Citations

This map shows the geographic impact of Michael Kann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kann more than expected).

Fields of papers citing papers by Michael Kann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kann. The network helps show where Michael Kann may publish in the future.

Co-authorship network of co-authors of Michael Kann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kann. A scholar is included among the top collaborators of Michael Kann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kann. Michael Kann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ringlander, Johan, Gustaf E. Rydell, & Michael Kann. (2025). From the Cytoplasm into the Nucleus—Hepatitis B Virus Travel and Genome Repair. Microorganisms. 13(1). 157–157.
2.
Yue, Lei, Gustaf E. Rydell, Maria Soller, et al.. (2025). Real-time genome imaging of host interactions in adeno-associated virus genome release. iScience. 28(6). 112624–112624. 1 indexed citations
3.
Kann, Michael, et al.. (2024). PERFIL EPIDEMIOLÓGICO DA MORTALIDADE HOSPITALAR POR TRANSTORNOS FALCIFORMES NO ESTADO DO RIO DE JANEIRO NOS ÚLTIMOS 10 ANOS. Hematology Transfusion and Cell Therapy. 46. S117–S118.
4.
Zoulim, Fabien, Adam Zlotnick, Stephanie Buchholz, et al.. (2022). Nomenclature of HBV core protein-targeting antivirals. Nature Reviews Gastroenterology & Hepatology. 19(12). 748–750. 40 indexed citations
5.
Mäntylä, Elina, et al.. (2021). Concepts to Reveal Parvovirus–Nucleus Interactions. Viruses. 13(7). 1306–1306. 11 indexed citations
6.
Magnius, Lars O., William S. Mason, John M. Taylor, et al.. (2020). ICTV Virus Taxonomy Profile: Hepadnaviridae. Journal of General Virology. 101(6). 571–572. 55 indexed citations
7.
Cazenave, Christian, Marie-Lise Blondot, Aurélia Cassany, et al.. (2017). The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids. Journal of Hepatology. 68(3). 441–448. 21 indexed citations
8.
Chen, Chao, Joseph Che‐Yen Wang, Elizabeth A. Pierson, et al.. (2016). Importin β Can Bind Hepatitis B Virus Core Protein and Empty Core-Like Particles and Induce Structural Changes. PLoS Pathogens. 12(8). e1005802–e1005802. 45 indexed citations
9.
Haryanto, Aris, et al.. (2012). Analysis of the nuclear localization signal of the hepatitis B virus capsid. 2(8). 174–185. 8 indexed citations
10.
Wittkop, Linda, Alexandra Schwarz, Aurélia Cassany, et al.. (2010). Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation. Cellular Microbiology. 12(7). 962–975. 40 indexed citations
11.
Rabe, Birgit, Andreas Bischof, Michael Foss, et al.. (2009). Nuclear Entry of Hepatitis B Virus Capsids Involves Disintegration to Protein Dimers followed by Nuclear Reassociation to Capsids. PLoS Pathogens. 5(8). e1000563–e1000563. 80 indexed citations
12.
Haryanto, Aris, Nastiti Wijayanti, & Michael Kann. (2007). Effect of the HBV Capsid Assembly Inhibitor Bayer 41-4109 on the Intracellular Localization of EGFP-Core Fusion Proteins. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Haryanto, Aris, Nastiti Wijayanti, & Michael Kann. (2007). Effect of Staurosporine on the Intracellular Localization of Hepatitis B Virus Core Protein. SHILAP Revista de lepidopterología. 12(1). 1 indexed citations
14.
Damianov, Andrey, Michael Kann, William S. Lane, & Albrecht Bindereif. (2006). Human RBM28 protein is a specific nucleolar component of the spliceosomal snRNPs. Biological Chemistry. 387(10/11). 1455–1460. 19 indexed citations
15.
Rösler, Christine, Josef Köck, Michael Kann, et al.. (2005). APOBEC‐mediated interference with hepadnavirus production†. Hepatology. 42(2). 301–309. 120 indexed citations
16.
Kann, Michael. (2004). Nucleoprotein Transport of HBV Capsid Particles. Humana Press eBooks. 95. 213–226. 2 indexed citations
17.
Köck, Josef, Michael Kann, Gerhard Pütz, Hubert E. Blum, & Fritz von Weizsäcker. (2003). Central Role of a Serine Phosphorylation Site within Duck Hepatitis B Virus Core Protein for Capsid Trafficking and Genome Release. Journal of Biological Chemistry. 278(30). 28123–28129. 36 indexed citations
18.
Motta, Iris, Carola G. Schipke, Helmut Kettenmann, et al.. (2002). Characterization of a mouse tet-on glia precursor cell line in vitro and in vivo using the electrophysiological measurement. Journal of Physiology-Paris. 96(3-4). 329–338. 2 indexed citations
19.
Ogbu, Cyprian O., P. Douglas Boatman, Ján Urban, et al.. (1998). Highly efficient and versatile synthesis of libraries of constrained β-strand mimetics. Bioorganic & Medicinal Chemistry Letters. 8(17). 2321–2326. 25 indexed citations
20.
Kann, Michael, et al.. (1993). Diagnostic significance of antibodies to hepatitis B virus polymerase in acutely and chronically HBV‐infected individuals. Journal of Medical Virology. 40(4). 285–290. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026